Symptoms, prevalence and impact of multiple sclerosis in younger patients: A multinational survey

Neuroepidemiology

Volumn 42, Issue 4, 2014, Pages 211-218

  Patti, Francesco ^a   Vila, Carlos ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b Global Medical Affairs Almirall SA ^*  (Spain)

Author keywords

Fatigue; Multiple sclerosis, epidemiology; Questionnaire; Spasticity; Survey

Indexed keywords

ADOLESCENT; ADULT; DAILY LIFE ACTIVITY; DIZZINESS; FATIGUE; FEMALE; GERMANY; HEALTH SURVEY; HUMAN; IMMOBILITY; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NORWAY; PAIN; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; REHABILITATION CARE; REVIEW; SLEEP DISORDER; SOCIAL INTERACTION; SPASTICITY; VISUAL DISORDER; AGE DISTRIBUTION; ARTICLE; DISEASE DURATION; ITALY; SOCIAL BEHAVIOR; SPAIN; SYMPTOM; COMPLICATION; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; GERMANY; HEALTH SURVEYS; HUMANS; ITALY; MALE; MULTIPLE SCLEROSIS; NORWAY; PREVALENCE; QUALITY OF LIFE; SPAIN; YOUNG ADULT;

EID: 84899770098     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000360423     Document Type: Review

References (16)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG: Multiple sclerosis. N Engl J Med 2000; 343: 938-952.
2. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L: Axonal transaction in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-285.
3. Richards RG, Sampson FC, Beard SM, Tappenden P: A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models. Health Technol Assess (Rockv) 2002; 6: 1-73.
4. Crayton HJ, Rossman HS: Managing the symptoms of multiple sclerosis: a multimodal approach. Clin Ther 2006; 28: 445-460.
5. Kobelt G, Pugliatti M: Cost of multiple sclerosis in Europe. Eur J Neurol 2005; 12(suppl 1): 63-67.
6. Uitdehaag BM, Barkhof F, Coyle PK, Gardner JD, Jeffery DR, Mikol DD: The changing face of multiple sclerosis clinical trial populations. Curr Med Res Opin 2011; 27: 1529-1537.
7. Mowry EM: Natural history of multiple sclerosis: early prognostic factors. Neurol Clin 2011; 29: 279-292.
8. Mohr DC, Dick LP, Russo D, Pinn J, Boudewyn AC, Likosky W, Goodkin DE: The psychosocial impact of multiple sclerosis: exploring the patient's perspective. Health Psychol 1999; 18: 376-382.
9. Feinstein A: Multiple sclerosis and depression. Mult Scler 2011; 17: 1276-1281.
10. Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL: Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 2004; 10: 589-595.
11. Hemmett L, Holmes J, Barnes M, Russell N: What drives quality of life in multiple sclerosis? QJM 2004;97: 671-676.
12. Opara JA, Jaracz K, Brola W: Quality of life in multiple sclerosis. J Med Life 2010; 3: 352-358.
13. Heesen C, Bohm J, Reich C, Kaspar J, Goebel M, Gold SM: Patients perceptions of bodily functions in multiple sclerosis: gait and visual function are the most valuated. Mult Scler 2008; 14: 988-991.
14. Jones KH, Ford DV, Jones PA, et al: How people with multiple sclerosis rate their quality of life: an EQ-5D survey via the UK MS register. PLOS One 2013; 8:e65640.
15. Delgado-Rodriguez M, Llorca J: Bias. J Epidemiol Community Health 2004; 58: 635-641.
16. Draugalis JR, Plaza CM: Best practices for survey research reports revisited: implications of target population, probability sampling, and response rate. Am J Pharm Educ 2009; 73: 142.